| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Aβ42|Amyloid Beta 42|Aβ|1-42|Aβ1-42 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, cerebrospinal fluid (CSF), Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
mouse Aβ42 (Amyloid Beta 42) is a molecular target commonly studied in neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of Aβ42 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Aβ42 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Aβ42 (Amyloid Beta 42) may also be referenced as Aβ42, Amyloid Beta 42, and Aβ in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Aβ42 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in neuroscience research.
- Interpreting shifts in Aβ42 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Aβ42 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease
IF: 9 Journal: Alzheimer's Research & Therapy Author: Department of Clinical Laboratory, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, 45 Changchun Street, Beijing, 100053, China. Cited Date: 2024-04-19
Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway
IF: 7.419 Journal: Biomedicine & Pharmacotherapy Cited Date: 2023-01-06
Neuroprotective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice
IF: 7.109 Journal: Cell Death Discovery Cited Date: 2023-01-28
Norboldine improves cognitive impairment and pathological features in Alzheimer's Disease by activating AMPK/GSK3β/Nrf2 signaling pathway
IF: 4.8 Journal: Journal of Ethnopharmacology Author: Affiliated Yongkang First People's Hospital and School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang 311399, China. Cited Date: 2024-07-05
PPM1D ameliorates Alzheimer's disease by promoting mitophagy
IF: 4.6 Journal: Experimental Neurology Author: Department of Neurology, Tieling Central Hospital, Tieling, Liaoning, People's Republic of China; Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China. Cited Date: 2025-03-21
From the Cover: Comparative Proteomics Reveals Silver Nanoparticles Alter Fatty Acid Metabolism and Amyloid Beta Clearance for Neuronal Apoptosis in a Triple Cell Coculture Model of the Blood–Brain Barrier
IF: 4.081 Journal: toxicological sciences Cited Date: 2017-07-04
Targeting Fyn Kinase for Alleviation of Cognitive Impairment in Streptozocin-Induced Alzheimer’s Disease in Mice by Loperamide; An Experimental and in Silico Analysis
IF: 3.8 Journal: Neurochemical Research Author: Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan. Cited Date: 2025-07-04
Combination of electroacupuncture and Liqi Yangyin formula treatment alleviates cognitive impairment and constipation in D-gal-induced mice via modulation of the brain-gut axis
IF: 3.7 Journal: Brain Research Bulletin Author: Department of Traditional Chinese Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Cited Date: 2025-07-11
Astragalin alleviates cognitive deficits and neuronal damage in SAMP8 mice through upregulating estrogen receptor expression
IF: 3.655 Journal: Metabolic Brain Disease Cited Date: 2022-08-25
A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis
IF: 3.4 Journal: Journal of Alzheimer’s Disease Author: Department of Neurology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, People's Republic of China. Cited Date: 2025-05-09
Ginsenoside Rg1 improves autophagy dysfunction to ameliorate Alzheimer's disease via targeting FGR proto-oncogene
IF: